Ian Travers and Keith O'Riordan lead Squib class at Frostbite Series; Isha Duggan tops 420 fleet at Kinsale Yacht Club.

Biopharmaceutical giant Bristol Myers Squibb (NYSE:BMY) reported fourth-quarter and full-year 2024 earnings on Thursday, Feb. 6, that topped analysts' consensus estimates. Adjusted earnings per ...

(RTTNews) - While reporting financial results for the fourth quarter on Thursday, Bristol-Myers Squibb Co. (BMY) initiated its adjusted earnings and revenue growth guidance for the full-year 2025.

Bristol Myers Squibb posted Q4 revenue of $12.34B, beating the consensus, with an 8% YoY increase driven by Growth Portfolio and Eliquis. Adjusted EPS was $1.67, topping the $1.46 consensus but ...

Just nine months after announcing a hefty plan to cut costs, Bristol Myers Squibb has gone one better, revealing a new goal to save even more money. The new plan, which has been dubbed a ...

Bristol Myers Squibb said it will slash $2 billion in costs by the end of 2027, expanding its ongoing cost-savings effort to chart a path toward long-term growth. The company also issued full ...

Bristol Myers Squibb (BMY) came out with quarterly earnings of $1.67 per share, beating the Zacks Consensus Estimate of $1.46 per share. This compares to earnings of $1.70 per share a year ago.

Shares in Bristol-Myers Squibb traded about 2.7% lower Thursday after the drug maker gave 2025 guidance that undershot expectations. Bristol expects sales of about $45.5 billion in 2025 ...

Pharma giant Bristol Myers Squibb is planning another round of cost cutting as part of a broader restructuring plan. Under the “strategic productivity initiative” announced Feb. 6, the ...

The Kinsale Yacht Club Custom Rigging Frostbite Series officially began on Sunday, February 2nd, after a week’s delay due to poor weather. Twelve Squibs launched into Kinsale Harbour waters, ...